Proxy Materials

Whitehawk Therapeutics, Inc. Filed 2023-04-28 Acc 0001628280-23-014004

Documents 1

2024-04-26 DEFA14A Proxy Materials
2023-05-05 4 Executive Chairman sold 2,305 shares at $7.57 ($17,445)
2023-05-03 4 Executive Chairman sold 39,695 shares at an average $7.71 ($306,192)
2023-04-28 DEFA14A Proxy Materials
2023-04-28 DEF 14A Proxy Statement
2023-04-28 ARS Annual Report to Security Holders
2022-04-26 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading form14a-definitiveaddition.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…